Cargando…
Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
BACKGROUND: Headache is an adverse event of coronavirus 2019 (COVID-19) vaccination. Whether patients with history of headache suffer more from vaccination-induced headaches is unknown. We aimed to uncover if headache patients develop more headaches after COVID-19 mRNA vaccination than healthy contr...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988452/ https://www.ncbi.nlm.nih.gov/pubmed/34407651 http://dx.doi.org/10.1177/03331024211038654 |
_version_ | 1784682963555844096 |
---|---|
author | Sekiguchi, Koji Watanabe, Narumi Miyazaki, Naoki Ishizuchi, Kei Iba, Chisato Tagashira, Yu Uno, Shunsuke Shibata, Mamoru Hasegawa, Naoki Takemura, Ryo Nakahara, Jin Takizawa, Tsubasa |
author_facet | Sekiguchi, Koji Watanabe, Narumi Miyazaki, Naoki Ishizuchi, Kei Iba, Chisato Tagashira, Yu Uno, Shunsuke Shibata, Mamoru Hasegawa, Naoki Takemura, Ryo Nakahara, Jin Takizawa, Tsubasa |
author_sort | Sekiguchi, Koji |
collection | PubMed |
description | BACKGROUND: Headache is an adverse event of coronavirus 2019 (COVID-19) vaccination. Whether patients with history of headache suffer more from vaccination-induced headaches is unknown. We aimed to uncover if headache patients develop more headaches after COVID-19 mRNA vaccination than healthy controls. METHODS: We performed a questionnaire survey for nursing staff in our hospital from April to May 2021. Based on baseline characteristics, we divided the participants into migraine, non-migrainous headache, and healthy control, and examined the occurrence and features of headache after COVID-19 vaccinations. RESULTS: We included 171 participants (15.2% migraine and 24.6% non-migrainous headache). Headache incidence after vaccinations was significantly higher in the migraine (69.2%) and non-migrainous headache (71.4%) groups than in the healthy control (37.9%) group. The incidence of headaches was significantly higher after the second dose compared to the first (45.6% vs. 20.5%). CONCLUSION: Migraineurs and non-migrainous headache participants developed more headaches compared to the healthy controls after COVID-19 vaccination. |
format | Online Article Text |
id | pubmed-8988452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-89884522022-04-08 Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study Sekiguchi, Koji Watanabe, Narumi Miyazaki, Naoki Ishizuchi, Kei Iba, Chisato Tagashira, Yu Uno, Shunsuke Shibata, Mamoru Hasegawa, Naoki Takemura, Ryo Nakahara, Jin Takizawa, Tsubasa Cephalalgia Brief Communications BACKGROUND: Headache is an adverse event of coronavirus 2019 (COVID-19) vaccination. Whether patients with history of headache suffer more from vaccination-induced headaches is unknown. We aimed to uncover if headache patients develop more headaches after COVID-19 mRNA vaccination than healthy controls. METHODS: We performed a questionnaire survey for nursing staff in our hospital from April to May 2021. Based on baseline characteristics, we divided the participants into migraine, non-migrainous headache, and healthy control, and examined the occurrence and features of headache after COVID-19 vaccinations. RESULTS: We included 171 participants (15.2% migraine and 24.6% non-migrainous headache). Headache incidence after vaccinations was significantly higher in the migraine (69.2%) and non-migrainous headache (71.4%) groups than in the healthy control (37.9%) group. The incidence of headaches was significantly higher after the second dose compared to the first (45.6% vs. 20.5%). CONCLUSION: Migraineurs and non-migrainous headache participants developed more headaches compared to the healthy controls after COVID-19 vaccination. SAGE Publications 2021-08-18 2022-03 /pmc/articles/PMC8988452/ /pubmed/34407651 http://dx.doi.org/10.1177/03331024211038654 Text en © International Headache Society 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Brief Communications Sekiguchi, Koji Watanabe, Narumi Miyazaki, Naoki Ishizuchi, Kei Iba, Chisato Tagashira, Yu Uno, Shunsuke Shibata, Mamoru Hasegawa, Naoki Takemura, Ryo Nakahara, Jin Takizawa, Tsubasa Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study |
title | Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study |
title_full | Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study |
title_fullStr | Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study |
title_full_unstemmed | Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study |
title_short | Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study |
title_sort | incidence of headache after covid-19 vaccination in patients with history of headache: a cross-sectional study |
topic | Brief Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988452/ https://www.ncbi.nlm.nih.gov/pubmed/34407651 http://dx.doi.org/10.1177/03331024211038654 |
work_keys_str_mv | AT sekiguchikoji incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy AT watanabenarumi incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy AT miyazakinaoki incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy AT ishizuchikei incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy AT ibachisato incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy AT tagashirayu incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy AT unoshunsuke incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy AT shibatamamoru incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy AT hasegawanaoki incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy AT takemuraryo incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy AT nakaharajin incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy AT takizawatsubasa incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy |